IBDEI04B ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5377,0)
 ;;=585.2^^40^402^3
 ;;^UTILITY(U,$J,358.3,5377,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5377,1,3,0)
 ;;=3^585.2
 ;;^UTILITY(U,$J,358.3,5377,1,4,0)
 ;;=4^CHR KIDNEY DIS STAGE II
 ;;^UTILITY(U,$J,358.3,5377,2)
 ;;=^332808
 ;;^UTILITY(U,$J,358.3,5378,0)
 ;;=585.3^^40^402^4
 ;;^UTILITY(U,$J,358.3,5378,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5378,1,3,0)
 ;;=3^585.3
 ;;^UTILITY(U,$J,358.3,5378,1,4,0)
 ;;=4^CHR KIDNEY DIS STAGE III
 ;;^UTILITY(U,$J,358.3,5378,2)
 ;;=^332809
 ;;^UTILITY(U,$J,358.3,5379,0)
 ;;=585.4^^40^402^5
 ;;^UTILITY(U,$J,358.3,5379,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5379,1,3,0)
 ;;=3^585.4
 ;;^UTILITY(U,$J,358.3,5379,1,4,0)
 ;;=4^CHR KIDNEY DIS STAGE IV
 ;;^UTILITY(U,$J,358.3,5379,2)
 ;;=^332810
 ;;^UTILITY(U,$J,358.3,5380,0)
 ;;=585.5^^40^402^6
 ;;^UTILITY(U,$J,358.3,5380,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5380,1,3,0)
 ;;=3^585.5
 ;;^UTILITY(U,$J,358.3,5380,1,4,0)
 ;;=4^CHR KIDNEY DIS STAGE V
 ;;^UTILITY(U,$J,358.3,5380,2)
 ;;=^332811
 ;;^UTILITY(U,$J,358.3,5381,0)
 ;;=585.6^^40^402^10
 ;;^UTILITY(U,$J,358.3,5381,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5381,1,3,0)
 ;;=3^585.6
 ;;^UTILITY(U,$J,358.3,5381,1,4,0)
 ;;=4^ESRD
 ;;^UTILITY(U,$J,358.3,5381,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,5382,0)
 ;;=281.1^^40^403^2
 ;;^UTILITY(U,$J,358.3,5382,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5382,1,3,0)
 ;;=3^281.1
 ;;^UTILITY(U,$J,358.3,5382,1,4,0)
 ;;=4^ANEMIA,B12 DEF
 ;;^UTILITY(U,$J,358.3,5382,2)
 ;;=^267974
 ;;^UTILITY(U,$J,358.3,5383,0)
 ;;=281.2^^40^403^3
 ;;^UTILITY(U,$J,358.3,5383,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5383,1,3,0)
 ;;=3^281.2
 ;;^UTILITY(U,$J,358.3,5383,1,4,0)
 ;;=4^ANEMIA,FOLATE DEF
 ;;^UTILITY(U,$J,358.3,5383,2)
 ;;=^259686
 ;;^UTILITY(U,$J,358.3,5384,0)
 ;;=280.9^^40^403^4
 ;;^UTILITY(U,$J,358.3,5384,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5384,1,3,0)
 ;;=3^280.9
 ;;^UTILITY(U,$J,358.3,5384,1,4,0)
 ;;=4^ANEMIA,IRON DEF
 ;;^UTILITY(U,$J,358.3,5384,2)
 ;;=^276946
 ;;^UTILITY(U,$J,358.3,5385,0)
 ;;=285.8^^40^403^1
 ;;^UTILITY(U,$J,358.3,5385,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5385,1,3,0)
 ;;=3^285.8
 ;;^UTILITY(U,$J,358.3,5385,1,4,0)
 ;;=4^ANEMIA NEC
 ;;^UTILITY(U,$J,358.3,5385,2)
 ;;=^87876
 ;;^UTILITY(U,$J,358.3,5386,0)
 ;;=282.2^^40^403^5
 ;;^UTILITY(U,$J,358.3,5386,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5386,1,3,0)
 ;;=3^282.2
 ;;^UTILITY(U,$J,358.3,5386,1,4,0)
 ;;=4^G6Pd DEFICIENCY
 ;;^UTILITY(U,$J,358.3,5386,2)
 ;;=^7225
 ;;^UTILITY(U,$J,358.3,5387,0)
 ;;=V08.^^40^403^6
 ;;^UTILITY(U,$J,358.3,5387,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5387,1,3,0)
 ;;=3^V08.
 ;;^UTILITY(U,$J,358.3,5387,1,4,0)
 ;;=4^HIV+ (ASYMPTOMATIC)
 ;;^UTILITY(U,$J,358.3,5387,2)
 ;;=^303392
 ;;^UTILITY(U,$J,358.3,5388,0)
 ;;=279.3^^40^403^7
 ;;^UTILITY(U,$J,358.3,5388,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5388,1,3,0)
 ;;=3^279.3
 ;;^UTILITY(U,$J,358.3,5388,1,4,0)
 ;;=4^IMMUNITY DEFICIENCY NOS
 ;;^UTILITY(U,$J,358.3,5388,2)
 ;;=^267969
 ;;^UTILITY(U,$J,358.3,5389,0)
 ;;=785.6^^40^403^8
 ;;^UTILITY(U,$J,358.3,5389,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5389,1,3,0)
 ;;=3^785.6
 ;;^UTILITY(U,$J,358.3,5389,1,4,0)
 ;;=4^LYMPHADENOPATHY
 ;;^UTILITY(U,$J,358.3,5389,2)
 ;;=^72368
 ;;^UTILITY(U,$J,358.3,5390,0)
 ;;=075.^^40^403^9
 ;;^UTILITY(U,$J,358.3,5390,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5390,1,3,0)
 ;;=3^075.
 ;;^UTILITY(U,$J,358.3,5390,1,4,0)
 ;;=4^MONONUCLEOSIS
 ;;^UTILITY(U,$J,358.3,5390,2)
 ;;=^62797
 ;;^UTILITY(U,$J,358.3,5391,0)
 ;;=238.4^^40^403^10
 ;;^UTILITY(U,$J,358.3,5391,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5391,1,3,0)
 ;;=3^238.4
 ;;^UTILITY(U,$J,358.3,5391,1,4,0)
 ;;=4^POLYCYTHEMIA VERA
 ;;^UTILITY(U,$J,358.3,5391,2)
 ;;=^304816
 ;;^UTILITY(U,$J,358.3,5392,0)
 ;;=282.49^^40^403^11
 ;;^UTILITY(U,$J,358.3,5392,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5392,1,3,0)
 ;;=3^282.49
 ;;^UTILITY(U,$J,358.3,5392,1,4,0)
 ;;=4^THALASSEMIA NEC
 ;;^UTILITY(U,$J,358.3,5392,2)
 ;;=^329910
 ;;^UTILITY(U,$J,358.3,5393,0)
 ;;=287.5^^40^403^12
 ;;^UTILITY(U,$J,358.3,5393,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5393,1,3,0)
 ;;=3^287.5
 ;;^UTILITY(U,$J,358.3,5393,1,4,0)
 ;;=4^THROMBOCYTOPENIA NOS
 ;;^UTILITY(U,$J,358.3,5393,2)
 ;;=^118988
 ;;^UTILITY(U,$J,358.3,5394,0)
 ;;=289.9^^40^403^13
 ;;^UTILITY(U,$J,358.3,5394,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5394,1,3,0)
 ;;=3^289.9
 ;;^UTILITY(U,$J,358.3,5394,1,4,0)
 ;;=4^THROMBOCYTOSIS
 ;;^UTILITY(U,$J,358.3,5394,2)
 ;;=^55344
 ;;^UTILITY(U,$J,358.3,5395,0)
 ;;=401.9^^40^404^1
 ;;^UTILITY(U,$J,358.3,5395,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5395,1,3,0)
 ;;=3^401.9
 ;;^UTILITY(U,$J,358.3,5395,1,4,0)
 ;;=4^HYPERTENSION NOS
 ;;^UTILITY(U,$J,358.3,5395,2)
 ;;=^186630
 ;;^UTILITY(U,$J,358.3,5396,0)
 ;;=401.1^^40^404^3
 ;;^UTILITY(U,$J,358.3,5396,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5396,1,3,0)
 ;;=3^401.1
 ;;^UTILITY(U,$J,358.3,5396,1,4,0)
 ;;=4^HYPERTENSION,BENIGN
 ;;^UTILITY(U,$J,358.3,5396,2)
 ;;=^269591
 ;;^UTILITY(U,$J,358.3,5397,0)
 ;;=401.0^^40^404^2
 ;;^UTILITY(U,$J,358.3,5397,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5397,1,3,0)
 ;;=3^401.0
 ;;^UTILITY(U,$J,358.3,5397,1,4,0)
 ;;=4^HYPERTENSION,ACCELERATED
 ;;^UTILITY(U,$J,358.3,5397,2)
 ;;=^73505
 ;;^UTILITY(U,$J,358.3,5398,0)
 ;;=227.0^^40^405^1
 ;;^UTILITY(U,$J,358.3,5398,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5398,1,3,0)
 ;;=3^227.0
 ;;^UTILITY(U,$J,358.3,5398,1,4,0)
 ;;=4^ADRENAL NEOPLASM,BENIGN
 ;;^UTILITY(U,$J,358.3,5398,2)
 ;;=^267688
 ;;^UTILITY(U,$J,358.3,5399,0)
 ;;=194.0^^40^405^2
 ;;^UTILITY(U,$J,358.3,5399,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5399,1,3,0)
 ;;=3^194.0
 ;;^UTILITY(U,$J,358.3,5399,1,4,0)
 ;;=4^ADRENAL NEOPLASM,MALIGNANT
 ;;^UTILITY(U,$J,358.3,5399,2)
 ;;=^267298
 ;;^UTILITY(U,$J,358.3,5400,0)
 ;;=255.10^^40^405^3
 ;;^UTILITY(U,$J,358.3,5400,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5400,1,3,0)
 ;;=3^255.10
 ;;^UTILITY(U,$J,358.3,5400,1,4,0)
 ;;=4^ALDOSTERONISM
 ;;^UTILITY(U,$J,358.3,5400,2)
 ;;=^330019
 ;;^UTILITY(U,$J,358.3,5401,0)
 ;;=255.0^^40^405^4
 ;;^UTILITY(U,$J,358.3,5401,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5401,1,3,0)
 ;;=3^255.0
 ;;^UTILITY(U,$J,358.3,5401,1,4,0)
 ;;=4^CUSHING'S SYNDROME
 ;;^UTILITY(U,$J,358.3,5401,2)
 ;;=^29802
 ;;^UTILITY(U,$J,358.3,5402,0)
 ;;=403.90^^40^405^6
 ;;^UTILITY(U,$J,358.3,5402,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5402,1,3,0)
 ;;=3^403.90
 ;;^UTILITY(U,$J,358.3,5402,1,4,0)
 ;;=4^HTN RENAL w/o RENAL FAILURE NOS
 ;;^UTILITY(U,$J,358.3,5402,2)
 ;;=^334272
 ;;^UTILITY(U,$J,358.3,5403,0)
 ;;=403.91^^40^405^5
 ;;^UTILITY(U,$J,358.3,5403,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5403,1,3,0)
 ;;=3^403.91
 ;;^UTILITY(U,$J,358.3,5403,1,4,0)
 ;;=4^HTN RENAL w/ RENAL FAILURE NOS
 ;;^UTILITY(U,$J,358.3,5403,2)
 ;;=^334242
 ;;^UTILITY(U,$J,358.3,5404,0)
 ;;=405.91^^40^405^7
 ;;^UTILITY(U,$J,358.3,5404,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5404,1,3,0)
 ;;=3^405.91
 ;;^UTILITY(U,$J,358.3,5404,1,4,0)
 ;;=4^HTN RENOVASCULAR NOS
 ;;^UTILITY(U,$J,358.3,5404,2)
 ;;=^269634
 ;;^UTILITY(U,$J,358.3,5405,0)
 ;;=403.00^^40^405^9
 ;;^UTILITY(U,$J,358.3,5405,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5405,1,3,0)
 ;;=3^403.00
 ;;^UTILITY(U,$J,358.3,5405,1,4,0)
 ;;=4^MAL HTN RENAL w/o RENAL FAILURE
 ;;^UTILITY(U,$J,358.3,5405,2)
 ;;=^334270
 ;;^UTILITY(U,$J,358.3,5406,0)
 ;;=403.01^^40^405^8
 ;;^UTILITY(U,$J,358.3,5406,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5406,1,3,0)
 ;;=3^403.01
 ;;^UTILITY(U,$J,358.3,5406,1,4,0)
 ;;=4^MAL HTN RENAL w/ RENAL FAILURE
 ;;^UTILITY(U,$J,358.3,5406,2)
 ;;=^334240
 ;;^UTILITY(U,$J,358.3,5407,0)
 ;;=405.01^^40^405^10
 ;;^UTILITY(U,$J,358.3,5407,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5407,1,3,0)
 ;;=3^405.01
 ;;^UTILITY(U,$J,358.3,5407,1,4,0)
 ;;=4^MAL HTN RENOVASCULAR
 ;;^UTILITY(U,$J,358.3,5407,2)
 ;;=^269628
 ;;^UTILITY(U,$J,358.3,5408,0)
 ;;=404.91^^40^406^1
 ;;^UTILITY(U,$J,358.3,5408,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5408,1,3,0)
 ;;=3^404.91
 ;;^UTILITY(U,$J,358.3,5408,1,4,0)
 ;;=4^HTN HRT/REN w/ CHF,NOS
 ;;^UTILITY(U,$J,358.3,5408,2)
 ;;=^334249
 ;;^UTILITY(U,$J,358.3,5409,0)
 ;;=404.93^^40^406^2
 ;;^UTILITY(U,$J,358.3,5409,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5409,1,3,0)
 ;;=3^404.93
 ;;^UTILITY(U,$J,358.3,5409,1,4,0)
 ;;=4^HTN HRT/REN w/ CHR&RF,NOS
 ;;^UTILITY(U,$J,358.3,5409,2)
 ;;=^334251
 ;;^UTILITY(U,$J,358.3,5410,0)
 ;;=404.90^^40^406^4
 ;;^UTILITY(U,$J,358.3,5410,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5410,1,3,0)
 ;;=3^404.90
 ;;^UTILITY(U,$J,358.3,5410,1,4,0)
 ;;=4^HTN HRT/REN w/o CHF/RF,NOS
 ;;^UTILITY(U,$J,358.3,5410,2)
 ;;=^334275
 ;;^UTILITY(U,$J,358.3,5411,0)
 ;;=404.92^^40^406^3
 ;;^UTILITY(U,$J,358.3,5411,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5411,1,3,0)
 ;;=3^404.92
 ;;^UTILITY(U,$J,358.3,5411,1,4,0)
 ;;=4^HTN HRT/REN w/ RENAL FAILURE,NOS
 ;;^UTILITY(U,$J,358.3,5411,2)
 ;;=^334250
 ;;^UTILITY(U,$J,358.3,5412,0)
 ;;=404.01^^40^406^5
 ;;^UTILITY(U,$J,358.3,5412,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5412,1,3,0)
 ;;=3^404.01
 ;;^UTILITY(U,$J,358.3,5412,1,4,0)
 ;;=4^MAL HTN HRT/REN w/ CHF
 ;;^UTILITY(U,$J,358.3,5412,2)
 ;;=^334243
 ;;^UTILITY(U,$J,358.3,5413,0)
 ;;=404.03^^40^406^6
 ;;^UTILITY(U,$J,358.3,5413,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5413,1,3,0)
 ;;=3^404.03
 ;;^UTILITY(U,$J,358.3,5413,1,4,0)
 ;;=4^MAL HTN HRT/REN w/ CHF&RF
 ;;^UTILITY(U,$J,358.3,5413,2)
 ;;=^334245
 ;;^UTILITY(U,$J,358.3,5414,0)
 ;;=404.00^^40^406^8
 ;;^UTILITY(U,$J,358.3,5414,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5414,1,3,0)
 ;;=3^404.00
 ;;^UTILITY(U,$J,358.3,5414,1,4,0)
 ;;=4^MAL HTN HRT/REN w/o CHF&RF
 ;;^UTILITY(U,$J,358.3,5414,2)
 ;;=^334273
 ;;^UTILITY(U,$J,358.3,5415,0)
 ;;=404.02^^40^406^7
 ;;^UTILITY(U,$J,358.3,5415,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5415,1,3,0)
 ;;=3^404.02
